BACKGROUND: Plasma is vital for the resuscitation of injured patients and to restore necessary procoagulants, especially Factors (F)II, FV, FVII, FX, and FXIII; however, female plasma has been implicated in the majority of transfusion-related acute lung injury (TRALI) cases and male-only plasma transfusion regimens have significantly decreased the incidence of TRALI. Little is known about the human plasma proteome, and no comparisons have been made between male and female plasma; therefore, we hypothesize that there are significant differences between plasma from male and female donors. STUDY DESIGN AND METHODS: Five units of fresh-frozen plasma each were collected from nulliparous female donors and male donors, and the proteome was analyzed by depleting the 14 most common proteins by immunoaffinity columns followed by protein separation by one dimension gel electrophoresis, tryptic digestion of the proteins, analysis of the peptides by liquid chromatography-tandem mass spectrometry, and identification employing human protein sequence databases. RESULTS: Female plasma versus male plasma contained pregnancy zone protein (419- to 580-fold), FV (twofold), α(1)-antitrypsin (twofold), β(2) -microglobulin (twofold), and Complement Factors H and C4B (1.5- to 2-fold) at significantly higher concentrations than males and males contained significant increases in Fc-binding protein (twofold), protein Z-dependent protease inhibitor (twofold), phosphatidylinositol glycan-specific phospholipase (fourfold), protein S-100 (threefold), and transgelin-2 (14-fold) versus females (p < 0.005). The increases in FV, α(1)-antitrypsin, and β(2)-microglobulin were confirmed by an activity assay or immunoblots. CONCLUSION: We conclude that there are proteomic differences between male and female plasma, which could be exploited to improve clinical outcomes in transfused patients.
BACKGROUND: Plasma is vital for the resuscitation of injured patients and to restore necessary procoagulants, especially Factors (F)II, FV, FVII, FX, and FXIII; however, female plasma has been implicated in the majority of transfusion-related acute lung injury (TRALI) cases and male-only plasma transfusion regimens have significantly decreased the incidence of TRALI. Little is known about the human plasma proteome, and no comparisons have been made between male and female plasma; therefore, we hypothesize that there are significant differences between plasma from male and female donors. STUDY DESIGN AND METHODS: Five units of fresh-frozen plasma each were collected from nulliparous female donors and male donors, and the proteome was analyzed by depleting the 14 most common proteins by immunoaffinity columns followed by protein separation by one dimension gel electrophoresis, tryptic digestion of the proteins, analysis of the peptides by liquid chromatography-tandem mass spectrometry, and identification employing human protein sequence databases. RESULTS: Female plasma versus male plasma contained pregnancy zone protein (419- to 580-fold), FV (twofold), α(1)-antitrypsin (twofold), β(2) -microglobulin (twofold), and Complement Factors H and C4B (1.5- to 2-fold) at significantly higher concentrations than males and males contained significant increases in Fc-binding protein (twofold), protein Z-dependent protease inhibitor (twofold), phosphatidylinositolglycan-specific phospholipase (fourfold), protein S-100 (threefold), and transgelin-2 (14-fold) versus females (p < 0.005). The increases in FV, α(1)-antitrypsin, and β(2)-microglobulin were confirmed by an activity assay or immunoblots. CONCLUSION: We conclude that there are proteomic differences between male and female plasma, which could be exploited to improve clinical outcomes in transfused patients.
Authors: Daniel W Cramer; Robert C Bast; Christine D Berg; Eleftherios P Diamandis; Andrew K Godwin; Patricia Hartge; Anna E Lokshin; Karen H Lu; Martin W McIntosh; Gil Mor; Christos Patriotis; Paul F Pinsky; Mark D Thornquist; Nathalie Scholler; Steven J Skates; Patrick M Sluss; Sudhir Srivastava; David C Ward; Zhen Zhang; Claire S Zhu; Nicole Urban Journal: Cancer Prev Res (Phila) Date: 2011-03
Authors: T Satoh; L M Brown; W A Blattner; E M Maloney; C C Kurman; D L Nelson; D Fuchs; H Wachter; D J Tollerud Journal: Clin Immunol Immunopathol Date: 1998-08
Authors: Anna M Zawadzka; Birgit Schilling; Jason M Held; Alexandria K Sahu; Michael P Cusack; Penelope M Drake; Susan J Fisher; Bradford W Gibson Journal: Electrophoresis Date: 2014-07-10 Impact factor: 3.535
Authors: Jessica R Santos-Parker; Keli S Santos-Parker; Matthew B McQueen; Christopher R Martens; Douglas R Seals Journal: J Appl Physiol (1985) Date: 2018-09-20
Authors: Ernest E Moore; Theresa L Chin; Michael C Chapman; Eduardo Gonzalez; Hunter B Moore; Christopher C Silliman; Kirk C Hansen; Angela Sauaia; Anirban Banerjee Journal: Shock Date: 2014-05 Impact factor: 3.454
Authors: Joshua B Brown; Francis X Guyette; Matthew D Neal; Jeffrey A Claridge; Brian J Daley; Brian G Harbrecht; Richard S Miller; Herb A Phelan; Peter W Adams; Barbara J Early; Andrew B Peitzman; Timothy R Billiar; Jason L Sperry Journal: Prehosp Emerg Care Date: 2015-02-06 Impact factor: 3.077
Authors: Luis Lee; Ernest E Moore; Kirk C Hansen; Christopher C Silliman; James G Chandler; Anirban Banerjee Journal: Surgery Date: 2012-11-02 Impact factor: 3.982
Authors: M Dzieciatkowska; C C Silliman; E E Moore; M R Kelher; A Banerjee; K J Land; M Ellison; F B West; D R Ambruso; K C Hansen Journal: Vox Sang Date: 2013-05-11 Impact factor: 2.144